The Alzheimer’s Clinical Trail Consortium (ACTC), led by research teams from the University of Southern California, San Diego, Harvard, and Mayo Clinic, was developed to accelerate research in Alzheimer’s and related neurodegenerative diseases. The University of Southern California has been awarded $13.98M from the National Institute on Aging (NIA), a branch of the National Institute of Health (NIH), who is leading the federal effort in this specialized field of research. The consortium’s objective is to find new and successful ways to treat and prevent this disorder, with support expected to total nearly $70 million over a five-year period. Additionally, another $19.8 million in funding has recently been awarded to the University of Southern California for other research projects related to Alzheimer’s disease and other related dementias.Read More
Science Market Update
The University of Southern California has a thriving regenerative medicine research headquarters at the Broad Center within the Keck School of Medicine. Established in 2006, the Center's $80M state-of-the-art building opened in 2010 to house eleven research teams and four core laboratories. In addition to seeking out therapeutics, though, a team of USC stem cell scientists is marrying their study of stem cell functioning to a more thorough understanding of regenerative biology as it happens naturally in many species of animal. Drs. Cheng-Ming Chuong, Randall B. Widelitz (right), Ping Wu, and Ting-Xin Jiang of the Department of Pathology discuss their lab research, which looks at stem cells in hair and feathers in particular, in a recent article published in the journal Physiology.